Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05879367
What this trial is testing

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme+4 more
Orbus Therapeutics, Inc. 66
Testing effectiveness (Phase 2)Study completedNCT01301430
What this trial is testing

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.

Who this might be right for
Glioblastoma Multiforme
Oryx GmbH & Co. KG 18
Testing effectiveness (Phase 2)Ended earlyNCT00479765
What this trial is testing

/ 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

Who this might be right for
Glioblastoma MultiformeBrain Neoplasms
Boston Scientific Corporation 4
Not applicableLooking for participantsNCT07831772
What this trial is testing

REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaNewly Diagnosed GlioblastomaBrain Tumor
University of Minnesota 4
Early research (Phase 1)Ended earlyNCT01269411
What this trial is testing

RO4929097 in Treating Patients With Recurrent Invasive Gliomas

Who this might be right for
Adult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 22
Large-scale testing (Phase 3)Study completedNCT00154375
What this trial is testing

Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma

Who this might be right for
Glioblastoma MultiformeAstrocytoma
Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)Study completedNCT00590681
What this trial is testing

Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
University of Chicago 62
Testing effectiveness (Phase 2)Study completedNCT00093964
What this trial is testing

Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor)

Who this might be right for
Glioblastoma Multiforme
EMD Serono 81
Testing effectiveness (Phase 2)Looking for participantsNCT07391215
What this trial is testing

5G-PEARL: Paxalisib in Malignant Brain Tumours

Who this might be right for
Malignant Primary GliomasGlioblastoma Multiforme (GBM)
Institute of Cancer Research, United Kingdom 64
Not applicableStudy completedNCT06038604
What this trial is testing

Glioblastoma Psychosocial Support Program

Who this might be right for
Glioblastoma
Duke University 11
Very early researchLooking for participantsNCT07493447
What this trial is testing

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Who this might be right for
MeningiomaGlioblastomaAcoustic Neuroma+2 more
Eben Rosenthal 30
Testing effectiveness (Phase 2)Ended earlyNCT01986348
What this trial is testing

Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Participants With Recurrent Gliomas

Who this might be right for
GlioblastomaGlioma
Karyopharm Therapeutics Inc 76
Testing effectiveness (Phase 2)Ended earlyNCT00062504
What this trial is testing

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+1 more
Teva Branded Pharmaceutical Products R&D, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT00331526
What this trial is testing

Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Hoag Memorial Hospital Presbyterian 83
Testing effectiveness (Phase 2)Study completedNCT00038493
What this trial is testing

Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00817284
What this trial is testing

Bevacizumab and Irinotecan or Bevacizumab and Temozolomide With Concomitant Radiotherapy for Primary Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Ulrik Lassen 60
Testing effectiveness (Phase 2)Looking for participantsNCT07093814
What this trial is testing

VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma

Who this might be right for
Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd. 42
Not applicableNot Yet RecruitingNCT07368283
What this trial is testing

Limited Target Volume Radiotherapy After Glioblastoma Surgery

Who this might be right for
Glioblastoma (GBM)
Jiangxi Provincial Cancer Hospital 79
Early research (Phase 1)Looking for participantsNCT05917145
What this trial is testing

ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma

Who this might be right for
Glioblastoma
Mayo Clinic 94
Early research (Phase 1)Study completedNCT01435395
What this trial is testing

Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Emory University 12
Next Page